Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis

By Takahashi Takehiro   Asano Yoshihide   Akamata Kaname   Aozasa Naohiko   Taniguchi Takashi   Noda Shinji   Masui Yuri   Ichimura Yohei   Toyama Tetsuo   Tamaki Zenshiro   Tada Yayoi   Sugaya Makoto   Kadono Takafumi   Sato Shinichi  

Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. : 884-890

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis

By Masui Yuri  

Modern Rheumatology, Vol. 23, Iss. 2, 2013-03 ,pp. : 323-329

Springer Publishing Company

Access to resources Recommend Favorite

Intermittent intravenous cyclophosphamide pulse therapy for the treatment of active interstitial lung disease associated with collagen vascular diseases

By Okada Makoto   Suzuki Kimihiro   Matsumoto Mitsuyo   Nakashima Masahiro   Nakanishi Takashi   Takada Kunio   Horikoshi Hideyuki   Matsubara Osamu   Ohsuzu Fumitaka  

Modern Rheumatology, Vol. 17, Iss. 2, 2007-04 ,pp. : 131-136

Springer Publishing Company

Access to resources Recommend Favorite

Interstitial Lung Disease in Systemic Sclerosis

By Ostojic Predrag   Cerinic Marco   Silver Richard   Highland Kristin   Damjanov Nemanja  

Lung, Vol. 185, Iss. 4, 2007-08 ,pp. : 211-220

Springer Publishing Company

Access to resources Recommend Favorite

Low‐dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease

By Valentini G.   Paone C.   La Montagna G.   Chiarolanza I.   Menegozzo M.   Colutta E.   Ruocco L.  

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 1, 2006-02 ,pp. : 35-38

Informa Healthcare

Access to resources Recommend Favorite